National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

Objectives Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SAR...

Full description

Bibliographic Details
Main Authors: Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Jutta G Richter, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Anja Strangfeld, Bimba F Hoyer, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/6/2/e001332.full

Internet

https://rmdopen.bmj.com/content/6/2/e001332.full

Similar Items